Finn Partners has acquired Medical & Health Consulting, Paris-headquartered firm that works for biopharma, technology and medical devices outfits, to bolster its position in Europe.
 |
|
Mina Volovitch, senior partner, Health, FINN Paris; Marie-Hélène Coste, MHC founding director and senior partner, Health, FINN Paris; and Gil Bashe, managing partner, FINN Global Health. |
Marie-Helene Coste, MHC founding director, will take on the role of senior director, health for Finn Europe. She will report to Chantal Bowman-Boyles, managing partner of Europe and Gil Bashe, managing partner of global health.
"MHC is one of France's most highly regarded medical device, life science and professional association consultancies and recognizes that when health professionals collaborate, the beneficiaries are the patients they seek to serve," Bashe told O'Dwyer's. "They are the ideal match for Finn in France."
Peter Finn noted that Coste and her firm "are renowned sector leaders and their work extends beyond France and Europe."
He called MHC a "perfect complement" to his firm's September acquisition of high-science healthcare firm Lazar Partners, a 22-member New York firm.
Finn Partners is O'Dwyer's No. 6-ranked healthcare company with $21.2M in fees in 2018.
The future of DTC should foster understanding and trust, as well as improving clinical conversations.
Healing the Sick Care System: Why People Matter, a new book from FINN Partners chair global health and purpose Gil Bashe, says that the current healthcare system is not broken because it lacks innovation, talent or investment, but because it has lost sight of the people it exists to serve.
Jeff Smokler, former president at healthcare specialist imre, joins Washington-based Avoq to head its PA practice.
